31/03/2021
2021-03-31
false
false
false
false
false
false
false
false
false
false
true
false
false
true
false
false
false
false
false
false
false
No description of principal activities is disclosed
2020-04-01
Sage Accounts Production 21.0 - FRS102_2019
xbrli:pure
xbrli:shares
iso4217:GBP
10955353
2020-04-01
2021-03-31
10955353
2021-03-31
10955353
2019-04-01
2020-03-31
10955353
2020-03-31
10955353
bus:RegisteredOffice
2020-04-01
2021-03-31
10955353
bus:LeadAgentIfApplicable
2020-04-01
2021-03-31
10955353
bus:Director1
2020-04-01
2021-03-31
10955353
bus:CompanySecretary1
2020-04-01
2021-03-31
10955353
core:WithinOneYear
2021-03-31
10955353
core:WithinOneYear
2020-03-31
10955353
core:ShareCapital
2021-03-31
10955353
core:ShareCapital
2020-03-31
10955353
core:RetainedEarningsAccumulatedLosses
2021-03-31
10955353
core:RetainedEarningsAccumulatedLosses
2020-03-31
10955353
core:CostValuation
core:Non-currentFinancialInstruments
2020-03-31
10955353
core:AdditionsToInvestments
core:Non-currentFinancialInstruments
2021-03-31
10955353
core:CostValuation
core:Non-currentFinancialInstruments
2021-03-31
10955353
core:Non-currentFinancialInstruments
2021-03-31
10955353
core:Non-currentFinancialInstruments
2020-03-31
10955353
bus:Director1
2020-03-31
10955353
bus:Director1
2021-03-31
10955353
bus:Director1
2019-03-31
10955353
bus:Director1
2020-03-31
10955353
bus:Director1
2019-04-01
2020-03-31
10955353
bus:SmallEntities
2020-04-01
2021-03-31
10955353
bus:AuditExemptWithAccountantsReport
2020-04-01
2021-03-31
10955353
bus:AbridgedAccounts
2020-04-01
2021-03-31
10955353
bus:SmallCompaniesRegimeForAccounts
2020-04-01
2021-03-31
10955353
bus:PrivateLimitedCompanyLtd
2020-04-01
2021-03-31
Company registration number:
10955353
Hathi Healthcare Limited
Unaudited filleted abridged financial statements
31 March 2021
Hathi Healthcare Limited
Contents
Directors and other information
Accountants report
Abridged statement of financial position
Notes to the financial statements
Hathi Healthcare Limited
Directors and other information
|
|
|
|
Director
|
Mr Sunil Jay Hathi
|
|
|
|
|
|
|
|
Secretary
|
Meena Hathi
|
|
|
|
|
|
|
|
Company number
|
10955353
|
|
|
|
|
|
|
|
Registered office
|
8 Sandymount Avenue
|
|
|
Stanmore
|
|
|
England
|
|
|
HA7 4TY
|
|
|
|
|
|
|
|
Accountants
|
Doshi & Co. Accountants
|
|
|
6th Floor AMP House
|
|
|
Dingwall Road
|
|
|
Croydon
|
|
|
CR0 2LX
|
|
|
|
Hathi Healthcare Limited
Report to the director on the preparation of the
unaudited statutory financial statements of Hathi Healthcare Limited
Year ended 31 March 2021
As described on the statement of financial position, the director of the company is responsible for the preparation of the financial statements for the year ended 31 March 2021 which comprise the abridged statement of financial position and related notes.
You consider that the company is exempt from an audit under the Companies Act 2006. In accordance with your instructions we have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to us.
Doshi & Co. Accountants
6th Floor AMP House
Dingwall Road
Croydon
CR0 2LX
26 September 2021
Hathi Healthcare Limited
Abridged statement of financial position
31 March 2021
|
|
|
2021
|
|
|
|
2020
|
|
|
|
|
Note
|
£
|
|
£
|
|
£
|
|
£
|
|
|
|
|
|
|
|
|
|
|
Fixed assets
|
|
|
|
|
|
|
|
|
|
Investments
|
|
5
|
188,670
|
|
|
|
81,845
|
|
|
|
|
|
_______
|
|
|
|
_______
|
|
|
|
|
|
|
|
188,670
|
|
|
|
81,845
|
|
|
|
|
|
|
|
|
|
|
Current assets
|
|
|
|
|
|
|
|
|
|
Debtors
|
|
|
2,681
|
|
|
|
-
|
|
|
Cash at bank and in hand
|
|
|
5,786
|
|
|
|
51,766
|
|
|
|
|
|
_______
|
|
|
|
_______
|
|
|
|
|
|
8,467
|
|
|
|
51,766
|
|
|
Creditors: amounts falling due
|
|
|
|
|
|
|
|
|
|
within one year
|
|
|
(
75,296)
|
|
|
|
(
61,370)
|
|
|
|
|
|
_______
|
|
|
|
_______
|
|
|
Net current liabilities
|
|
|
|
|
(
66,829)
|
|
|
|
(
9,604)
|
|
|
|
|
|
_______
|
|
|
|
_______
|
Total assets less current liabilities
|
|
|
|
|
121,841
|
|
|
|
72,241
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
_______
|
|
|
|
_______
|
Net assets
|
|
|
|
|
121,841
|
|
|
|
72,241
|
|
|
|
|
|
_______
|
|
|
|
_______
|
|
|
|
|
|
|
|
|
|
|
Capital and reserves
|
|
|
|
|
|
|
|
|
|
Called up share capital
|
|
|
|
|
1
|
|
|
|
1
|
Profit and loss account
|
|
|
|
|
121,840
|
|
|
|
72,240
|
|
|
|
|
|
_______
|
|
|
|
_______
|
Shareholder funds
|
|
|
|
|
121,841
|
|
|
|
72,241
|
|
|
|
|
|
_______
|
|
|
|
_______
|
|
|
|
|
|
|
|
|
|
|
For the year ending 31 March 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
-
The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
-
The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the abridged statement of comprehensive income has not been delivered.
All of the members have consented to the preparation of the abridged statement of comprehensive income and the abridged statement of financial position for the current year ending 31 March 2021 in accordance with Section 444(2A) of the Companies Act 2006.
These financial statements were approved by the
board of directors
and authorised for issue on
26 September 2021
, and are signed on behalf of the board by:
Mr Sunil Jay Hathi
Director
Company registration number:
10955353
Hathi Healthcare Limited
Notes to the financial statements
Year ended 31 March 2021
1.
General information
The company is a private company limited by shares, registered in United Kingdom. The address of the registered office is 8 Sandymount Avenue, Stanmore, England, HA7 4TY.
2.
Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'. The Triennial review 2017 amendments to the standard have been early adopted.
3.
Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Turnover
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Fixed asset investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses. Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4.
Staff costs
The average number of persons employed by the company during the year amounted to
1
(2020:
1
).
The aggregate payroll costs incurred during the year were:
|
|
|
2021
|
2020
|
|
|
|
£
|
£
|
|
Wages and salaries
|
|
11,875
|
8,632
|
|
|
|
_______
|
_______
|
|
|
|
|
|
5.
Investments
|
|
|
|
|
|
|
|
|
|
£
|
|
|
|
|
|
|
Cost
|
|
|
|
|
|
|
|
At 1 April 2020
|
81,845
|
|
|
|
|
|
|
Additions
|
106,825
|
|
|
|
|
|
|
|
_______
|
|
|
|
|
|
|
At 31 March 2021
|
188,670
|
|
|
|
|
|
|
|
_______
|
|
|
|
|
|
|
Impairment
|
|
|
|
|
|
|
|
At 1 April 2020 and 31 March 2021
|
-
|
|
|
|
|
|
|
|
_______
|
|
|
|
|
|
|
Carrying amount
|
|
|
|
|
|
|
|
At 31 March 2021
|
188,670
|
|
|
|
|
|
|
|
_______
|
|
|
|
|
|
|
At 31 March 2020
|
81,845
|
|
|
|
|
|
|
|
_______
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6.
Events after the end of the reporting period
After the balance sheet date, we have seen macro-economic uncertainty with regard to the general trading conditions as a result of COVID-19 (coronavirus) outbreak leading to disruption to business activity. The directors consider the emergence and spread of COVID-19 to be non-adjusting post-balance sheet event . Given the inherent uncertainties, it is not practicable at this time to determine the impact of COVID-19 on the company or provide a quantitative estimate of this impact. We confirm that no other event has occurred between the Balance Sheet date and the date of approval of these accounts, which will materially affect the amounts or manner in which significant items are reflected in the accounts.
7.
Directors advances, credits and guarantees
|
During the year the director entered into the following advances and credits with the company:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2021
|
|
|
|
|
|
|
|
|
|
Balance brought forward
|
Advances /(credits) to the director
|
Balance o/standing
|
|
|
|
|
|
£
|
£
|
£
|
|
|
|
|
Mr Sunil Jay Hathi
|
(
52,209)
|
(
7,746)
|
(
59,955)
|
|
|
|
|
|
_______
|
_______
|
_______
|
|
|
|
|
|
|
|
|
|
|
|
2020
|
|
|
|
|
|
|
|
|
|
Balance brought forward
|
Advances /(credits) to the director
|
Balance o/standing
|
|
|
|
|
|
£
|
£
|
£
|
|
|
|
|
Mr Sunil Jay Hathi
|
(
42,884)
|
(
9,325)
|
(
52,209)
|
|
|
|
|
|
_______
|
_______
|
_______
|
|
|
|
|
|
|
|
|
|
|
|